Carlos A Buxo Tirado, MD | |
Y38 Boulevard Monroig, Cuarta Seccion Levittown, Toa Baja, PR 00949 | |
(787) 200-0324 | |
(787) 200-0325 |
Full Name | Carlos A Buxo Tirado |
---|---|
Gender | Male |
Speciality | Interventional Pain Management |
Experience | 24 Years |
Location | Y38 Boulevard Monroig, Toa Baja, Puerto Rico |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285660373 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207LP2900X | Anesthesiology - Pain Medicine | 14329 (Puerto Rico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Carlos A Buxo Tirado, MD Po Box 51519, Toa Baja, PR 00950-1519 Ph: (787) 200-0324 | Carlos A Buxo Tirado, MD Y38 Boulevard Monroig, Cuarta Seccion Levittown, Toa Baja, PR 00949 Ph: (787) 200-0324 |
News Archive
Developing arthritis increases the risk of falling into poverty, especially for women, new research shows. In a study of more than 4,000 Australian adults, females who developed arthritis were 51% more likely to fall into income poverty than nonarthritic women. In men, arthritis was linked with a 22% increased risk.
Drug-induced liver disease (DILD), a potential complication seen with some medications, is usually not life-threatening, but may occasionally be more severe with a high mortality, requiring a liver transplant in selected cases.
Hollis-Eden Pharmaceuticals, Inc., today reported preliminary results of its ongoing Phase I/II clinical trial with Apoptone® (HE3235) for hormone-resistant prostate cancer (also called castrate-resistant prostate cancer or CRPC). Presented at the Molecular Targets and Cancer Therapeutics Conference, which is co-sponsored by the AACR, NCI and EORTC, the poster is titled: "Results of preclinical and clinical Phase I/II open-label dose-ranging trial with HE3235, a synthetic adrenal hormone, in Castrate Resistant Prostate Cancer (CRPC)."
Since 1970, life expectancy around the world has risen dramatically, with people living more than 10 years longer. That's the good news.
Lilly USA and the National Committee for Quality Assurance have collaborated to release a free online guide and resource library for health care organizations that wish to undertake quality improvement initiatives to improve culturally and linguistically appropriate services and reduce disparities in care.
› Verified 7 days ago